Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
PAVmed Inc
F:1P5
|
US |
|
R
|
Reconnaissance Energy (Africa) Ltd
OTC:RECAF
|
CA |
|
Conrad Asia Energy Ltd
F:3MD
|
ID |
|
T
|
Thomson Reuters Corp
LSE:0Q89
|
CA |
|
ROK Resources Inc
XTSX:ROK
|
CA |
|
P
|
Pros Holdings Inc
F:PH2
|
US |
|
S
|
Sun Communities Inc
F:SCZ
|
US |
|
N
|
National Retail Properties Inc
F:CZ2
|
US |
|
F
|
Francotyp Postalia Holding AG
DUS:FPH
|
DE |
|
ActiveOps PLC
F:95D
|
UK |
|
S
|
Sixt SE
XHAM:SIX2
|
DE |
|
P
|
PTC Inc
XMUN:PMTA
|
US |
|
S
|
Semtech Corp
XMUN:SM2
|
US |
|
M
|
mBank SA
SWB:BRU
|
PL |
|
Iluka Resources Ltd
ASX:ILU
|
AU |
|
S
|
Sumitomo Chemical Co Ltd
F:SMM
|
JP |
|
S
|
Semtech Corp
F:SM2
|
US |
|
O
|
Orezone Gold Corp
SWB:OEX
|
CA |
Bankruptcy Probability
Rhythm Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rhythm Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
454.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rhythm Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rhythm Pharmaceuticals Inc has total debt of 98.3m USD. This includes both short-term (0 USD) and long-term (98.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
